Chinese herbal medicine in pediatric oncology: Effects on survival and toxicity – a meta-analysis
CHM shows promise as a complementary therapy in pediatric oncology, particularly in reducing the toxicities of conventional cancer treatments and supporting immune function. However, further large-scale, multicenter trials are needed to establish standardized protocols for its integration of CHM into pediatric cancer care.
Authors
- Ágnes Lilla Szilágyi (ORCID: https://orcid.org/0000-0003-1584-5906)
- Péter Hegyi
- Miklós Garami (ORCID: https://orcid.org/0000-0003-4298-2746)
- Gergely Agócs (ORCID: https://orcid.org/0000-0003-2489-3790)
- Andrea Párniczky (ORCID: https://orcid.org/0000-0003-3466-4780)
- Ágnes Eszter Tímár (ORCID: https://orcid.org/0000-0001-5078-1499)
- X. Li (ORCID: https://orcid.org/0009-0007-5467-1167)
- Márk Hernádfői (ORCID: https://orcid.org/0009-0007-8653-2292)
- Rita Nagy (ORCID: https://orcid.org/0000-0002-2663-4912)
- Gefu Cai
- Xinyi Qian (ORCID: https://orcid.org/0009-0006-0722-1983)
Institutions
- Semmelweis University (HU)
- University of Pecs (HU)
Publication Details
- Journal
- Phytomedicine
- Published
- 2025-12-17
- DOI
- https://doi.org/10.1016/j.phymed.2025.157723
- Primary Topic
- Complementary and Alternative Medicine Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00